FIL Ltd - Sep 16, 2024 Form 4 Insider Report for Bicara Therapeutics Inc. (BCAX)

Role
Other*
Signature
Stephanie J. Brown, Duly authorized under Powers of Attorney, by and on behalf of FIL Limited, Eight Roads Shareholdings Limited, and its direct and indirect subsidiaries, Eight Roads Holdings Limited and Eight Roads GP
Stock symbol
BCAX
Transactions as of
Sep 16, 2024
Transactions value $
$0
Form type
4
Date filed
9/18/2024, 11:54 AM
Previous filing
Sep 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAX Common Stock Conversion of derivative security +54.1K 54.1K Sep 16, 2024 Eight Roads Ventures India Healthcare IV, L.P. F1
transaction BCAX Common Stock Conversion of derivative security +607K +1121.95% 661K Sep 16, 2024 Eight Roads Ventures India Healthcare IV, L.P. F1
transaction BCAX Common Stock Conversion of derivative security +353K +53.39% 1.01M Sep 16, 2024 Eight Roads Ventures India Healthcare IV, L.P. F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAX Series Seed Preferred Stock Conversion of derivative security -54.1K -100% 0 Sep 16, 2024 Common Stock 54.1K Eight Roads Ventures India Healthcare IV, L.P. F1
transaction BCAX Series B Preferred Stock Conversion of derivative security -607K -100% 0 Sep 16, 2024 Common Stock 607K Eight Roads Ventures India Healthcare IV, L.P. F1
transaction BCAX Series C Preferred Stock Conversion of derivative security -353K -100% 0 Sep 16, 2024 Common Stock 353K Eight Roads Ventures India Healthcare IV, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

FIL Ltd is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On September 16, 2024, in connection with the completion of the issuer's initial public offering, each share of Series Seed, B, and C Preferred Shares converted on a 1-for-1 basis into shares of Common Stock.

Remarks:

Remark 1: Eight Roads Shareholdings Limited ("ERSL") and Pandanus Partners, LP ("Pandanus") own voting stock of Eight Roads Holdings Limited ("ERHL"). ERHL is the indirect parent company of Eight Roads GP ("ERGP") which is the ultimate general partner of the limited partnership which owns the shares being reported on with this Form. The percentage of total voting power represented by ERSL and Pandanus shares of ERHL voting stock may fluctuate due to changes in the total number of shares of ERHL voting stock outstanding from time to time, ERSL's holdings represents more than 50% and Pandanus' holding represents more than 25% and less than 50% of, the total votes which may be cast by all holders of ERHL voting stock. The shares in ERSL are owned primarily by officers and senior employees of FIL Limited and Eight Roads together with several charitable organizations. No such person or organization owns or controls more than 25% of the voting stock in ERSL. Pandanus Associates, Inc. ("PAI") acts as general partner of Pandanus. Pandanus is owned by trusts for the benefit of members of the Johnson family, including ERHL's Chairman Abigail P. Johnson, but disclaims that any such member is a beneficial owner of the securities reported on this form. The address of ERSL, ERHL and ERGP is 42 Crow Lane, Pembroke HM19, Bermuda. The address of Pandanus is c/o FIL Ltd, 42 Crow Lane, Pembroke HM19, Bermuda. The address of PAI is 11 Keewaydin Drive, Suite 100, Salem, NH, USA, 03079. Eight Roads Ventures India Healthcare IV, L.P is a limited partnership ("ERVI HC"). The General Partners of ERVI HC is Eight Roads Ventures India Healthcare Advisors IV, L.P. ("ERVI HCA"). The general partner of ERVI HCA is ERGP, which is ultimately controlled by ERSL. Remark 2: The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the undersigned are the beneficial owners of any securities reported herein.